tiprankstipranks
Liquidia Technologies (LQDA)
NASDAQ:LQDA
US Market
Want to see LQDA full AI Analyst Report?

Liquidia Technologies (LQDA) Stock Forecast & Price Target

738 Followers
See the Price Targets and Ratings of:

LQDA Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Liquidia
Technologies
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LQDA Stock 12 Month Forecast

Average Price Target

$64.83
▲(64.26% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Liquidia Technologies in the last 3 months. The average price target is $64.83 with a high forecast of $71.00 and a low forecast of $59.00. The average price target represents a 64.26% change from the last price of $39.47.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","72":"$72","26.25":"$26.3","41.5":"$41.5","56.75":"$56.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$71.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.83333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$64.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$59.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,26.25,41.5,56.75,72],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.14,40.667692307692306,43.19538461538462,45.723076923076924,48.25076923076923,50.77846153846154,53.30615384615385,55.83384615384615,58.36153846153846,60.88923076923077,63.41692307692308,65.94461538461539,68.4723076923077,{"y":71,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.14,40.193333333333335,42.24666666666667,44.3,46.35333333333333,48.406666666666666,50.459999999999994,52.51333333333333,54.56666666666666,56.62,58.67333333333333,60.72666666666666,62.779999999999994,{"y":64.83333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.14,39.744615384615386,41.34923076923077,42.95384615384616,44.558461538461536,46.16307692307692,47.76769230769231,49.37230769230769,50.97692307692308,52.58153846153846,54.18615384615384,55.79076923076923,57.395384615384614,{"y":59,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.98,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.68,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.05,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.36,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.05,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.49,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.21,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.94,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.47,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$71.00Average Price Target$64.83Lowest Price Target$59.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on LQDA
LifeSci Capital
LifeSci Capital
$71
Buy
79.88%
Upside
Reiterated
05/16/26
Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)
Bank of America Securities Analyst forecast on LQDA
Bank of America Securities
Bank of America Securities
Buy
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: RxSight (NASDAQ: RXST), Liquidia Technologies (NASDAQ: LQDA) and Krystal Biotech (NASDAQ: KRYS)
H.C. Wainwright Analyst forecast on LQDA
H.C. Wainwright
H.C. Wainwright
$55$67
Buy
69.75%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Liquidia Technologies (NASDAQ: LQDA)
BTIG
$50$59
Buy
49.48%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Health Catalyst (NASDAQ: HCAT), Liquidia Technologies (NASDAQ: LQDA) and Bicara Therapeutics Inc. (NASDAQ: BCAX)
Needham
$54$70
Buy
77.35%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Exagen (NASDAQ: XGN) and Liquidia Technologies (NASDAQ: LQDA)
Wells Fargo Analyst forecast on LQDA
Wells Fargo
Wells Fargo
$51$62
Buy
57.08%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Chugai Pharmaceutical Co (Other OTC: CHGCF), Liquidia Technologies (NASDAQ: LQDA) and Health Catalyst (NASDAQ: HCAT)
Jefferies Analyst forecast on LQDA
Jefferies
Jefferies
$57$60
Buy
52.01%
Upside
Assigned
05/11/26
Liquidia price target raised to $60 from $57 at JefferiesLiquidia price target raised to $60 from $57 at Jefferies
Raymond James Analyst forecast on LQDA
Raymond James
Raymond James
$41$47
Buy
19.08%
Upside
Reiterated
11/04/25
Liquidia price target raised to $47 from $41 at Raymond JamesLiquidia price target raised to $47 from $41 at Raymond James
Scotiabank Analyst forecast on LQDA
Scotiabank
Scotiabank
$37
Buy
-6.26%
Downside
Reiterated
06/11/25
Liquidia Technologies (LQDA) Gets a Buy from Scotiabank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on LQDA
LifeSci Capital
LifeSci Capital
$71
Buy
79.88%
Upside
Reiterated
05/16/26
Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)
Bank of America Securities Analyst forecast on LQDA
Bank of America Securities
Bank of America Securities
Buy
Reiterated
05/14/26
Analysts Conflicted on These Healthcare Names: RxSight (NASDAQ: RXST), Liquidia Technologies (NASDAQ: LQDA) and Krystal Biotech (NASDAQ: KRYS)
H.C. Wainwright Analyst forecast on LQDA
H.C. Wainwright
H.C. Wainwright
$55$67
Buy
69.75%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Liquidia Technologies (NASDAQ: LQDA)
BTIG
$50$59
Buy
49.48%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Health Catalyst (NASDAQ: HCAT), Liquidia Technologies (NASDAQ: LQDA) and Bicara Therapeutics Inc. (NASDAQ: BCAX)
Needham
$54$70
Buy
77.35%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Exagen (NASDAQ: XGN) and Liquidia Technologies (NASDAQ: LQDA)
Wells Fargo Analyst forecast on LQDA
Wells Fargo
Wells Fargo
$51$62
Buy
57.08%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Chugai Pharmaceutical Co (Other OTC: CHGCF), Liquidia Technologies (NASDAQ: LQDA) and Health Catalyst (NASDAQ: HCAT)
Jefferies Analyst forecast on LQDA
Jefferies
Jefferies
$57$60
Buy
52.01%
Upside
Assigned
05/11/26
Liquidia price target raised to $60 from $57 at JefferiesLiquidia price target raised to $60 from $57 at Jefferies
Raymond James Analyst forecast on LQDA
Raymond James
Raymond James
$41$47
Buy
19.08%
Upside
Reiterated
11/04/25
Liquidia price target raised to $47 from $41 at Raymond JamesLiquidia price target raised to $47 from $41 at Raymond James
Scotiabank Analyst forecast on LQDA
Scotiabank
Scotiabank
$37
Buy
-6.26%
Downside
Reiterated
06/11/25
Liquidia Technologies (LQDA) Gets a Buy from Scotiabank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Liquidia Technologies

3 Months
Jason GerberryBank of America Securities
Success Rate
11/13 ratings generated profit
85%
Average Return
+26.71%
Copying Jason Gerberry's trades and holding each position for 3 Months would result in 84.62% of your transactions generating a profit, with an average return of +26.71% per trade.
1 Year
Jason GerberryBank of America Securities
Success Rate
13/13 ratings generated profit
100%
Average Return
+137.43%
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +137.43% per trade.
2 Years
Jason GerberryBank of America Securities
Success Rate
13/13 ratings generated profit
100%
Average Return
+264.19%
Copying Jason Gerberry's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +264.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LQDA Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
7
1
5
5
4
Buy
4
4
6
5
14
Hold
0
0
0
0
1
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
11
5
12
11
20
In the current month, LQDA has received 18 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. LQDA average Analyst price target in the past 3 months is 64.83.
Each month's total comprises the sum of three months' worth of ratings.

LQDA Financial Forecast

LQDA Earnings Forecast

Next quarter’s earnings estimate for LQDA is $0.79 with a range of $0.57 to $0.97. The previous quarter’s EPS was $0.52. LQDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.
Next quarter’s earnings estimate for LQDA is $0.79 with a range of $0.57 to $0.97. The previous quarter’s EPS was $0.52. LQDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.

LQDA Sales Forecast

Next quarter’s sales forecast for LQDA is $170.98M with a range of $164.06M to $180.90M. The previous quarter’s sales results were $132.87M. LQDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.
Next quarter’s sales forecast for LQDA is $170.98M with a range of $164.06M to $180.90M. The previous quarter’s sales results were $132.87M. LQDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.

LQDA Stock Forecast FAQ

What is LQDA’s average 12-month price target, according to analysts?
Based on analyst ratings, Liquidia Technologies’s 12-month average price target is 64.83.
    What is LQDA’s upside potential, based on the analysts’ average price target?
    Liquidia Technologies has 64.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is LQDA a Buy, Sell or Hold?
          Liquidia Technologies has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Liquidia Technologies’s price target?
            The average price target for Liquidia Technologies is 64.83. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $71.00 ,the lowest forecast is $59.00. The average price target represents 64.26% Increase from the current price of $39.47.
              What do analysts say about Liquidia Technologies?
              Liquidia Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of LQDA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.